Cystic Fibrosis Foundation distributed the following clinical trial update in November. Click the trial title to get more details.
This alert was issued on November 2nd:
IGNITE: Safety and effectiveness of gallium nitrate in adults with cystic fibrosis
Status: Completed with results
Description: This study evaluated the safety and effectiveness of intravenous (IV) gallium nitrate in adults with CF who are chronically infected with Pseudomonas aeruginosa.
Age: 18 Years and Older
Mutation: No Mutation Requirement
Fev1% Predicted: 25% or greater
Number of Visits: 5
Length of Participation: 63 days
CliicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT02354859